Status:
WITHDRAWN
Impact of 5-Fluorouracil (5-FU) on Cancer Cells From Liver Metastases of Colon Cancer
Lead Sponsor:
Centre Leon Berard
Conditions:
Cancer of Colon
Metastasis to Liver
Eligibility:
All Genders
18+ years
Brief Summary
Analyze the dynamics of incorporation of 5-fluorouracil into cancer cell ribosomes from liver metastases of patient with metastatic colon cancer.
Detailed Description
This is a monocentric, prospective, non-interventional cohort study in adult patients with metastatic colon cancer with hepatics metastasis. Tumour samples collected for this study include: * A frag...
Eligibility Criteria
Inclusion
- Patient with metastatic colon cancer operated on and followed up at the Centre Leon Berard for liver metastasis.
- Patient affiliated to social security
Exclusion
- Other pathologies that may interfere with biological evaluation, in particular known hepatic cirrhosis, whatever its origin, other liver overload diseases (hemochromatosis, Wilson's disease), but excluding steatosis (which can be chemo-induced).
Key Trial Info
Start Date :
June 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2023
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04274790
Start Date
June 1 2021
End Date
March 1 2023
Last Update
February 14 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Léon Bérard
Lyon, France, 69008